Dr. Walker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 NE 10th St
# OUPB5200
Oklahoma City, OK 73104Phone+1 405-271-7770
Education & Training
- University of California (Irvine)Fellowship, Gynecologic Oncology, 1988 - 1990
- University of California (Irvine)Residency, Gynecologic Oncology, 1986 - 1990
- University of California (Irvine)Fellowship, Gynecologic Oncology, 1986 - 1987
- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1982 - 1986
- David Geffen School of Medicine at UCLAClass of 1982
Certifications & Licensure
- OK State Medical License 1990 - 2025
- CA State Medical License 1985 - 2020
- PA State Medical License 1984 - 2004
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus Start of enrollment: 1996 Apr 01
- Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix Start of enrollment: 1999 Nov 01
- Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Start of enrollment: 1999 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1365 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M. Wolf, Alexander J. Lazar
Cell. 2018-04-05 - 65 citationsLapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancerKimberly K. Leslie, Michael W. Sill, Heather A. Lankes, Edgar G. Fischer, Andrew K. Godwin
Gynecologic Oncology. 2012-11-01 - 127 citationsA phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncol...David H. Moore, Shamshad Ali, Wui Jin Koh, Helen Michael, Mack N. Barnes
Gynecologic Oncology. 2011-03-01
Press Mentions
- Stephenson Cancer Center Gets 2.2 Million Grant to Fund Cervical Cancer PreventionJune 22nd, 2016
Grant Support
- Expression Of MN Protein In Agcus As Potential Biomarker Of Dysplasia/NeoplasiaNational Center For Research Resources2004–2006
- A Study To Understand Cervical Cancer Early Endpoints And Determinants (SUCCEED)National Center For Research Resources2005
- Prevalence Of Symptoms Suggestive Of Ovarian CancerNational Center For Research Resources2004–2005
- Outcomes In Gynecologic CancerNational Center For Research Resources2004–2005
- Study To Understand Cervical Cancer Early Endpoints AnNational Center For Research Resources2004
- Pivotal Study II: Single-Arm Multi-Ctr. Study Of ODS As Adjunct To ColposcopyNational Center For Research Resources2004
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: